Sarcopenia, a disorder that involves the generalized loss of skeletal muscle strength and
mass, was formally recognized as a disease by its inclusion in the International …

The rise in the number of people aged 65 years and older living with inflammatory rheumatic
diseases such as rheumatoid arthritis is causing considerable challenges for clinicians. As …

People with rheumatoid arthritis (RA) have both disease-specific risk factors for osteoporosis
and fractures in addition to those that affect the general population. Disease specific risks …

To examine the prevalence of sarcopenia and its association with antirheumatic drugs in
adults with rheumatoid arthritis (RA). This review was registered on PROSPERO and …

Abstract Interleukin (IL)-6 is produced locally in response to an inflammatory stimulus, and is
able to induce systemic manifestations at distance from the site of inflammation. Its unique …

Sarcopenia is characterized by loss of muscle mass, altered muscle composition, fat and
fibrous tissue infiltration, and abnormal innervation, especially in older individuals with …

Difficult-to-treat rheumatoid arthritis is a heterogeneous term in which patients may present
with difficulties in their management for different reasons. This can ultimately lead to patients …

Objective In rheumatoid arthritis (RA), chronic inflammation can enhance the development of
sarcopenia with a depletion of muscle mass, strength and performance. Currently, a …

This review summarizes the evidence for the management of sarcopenia in patients with
rheumatoid arthritis (RA) in terms of drugs, exercise, and nutrition. Sarcopenia is a decrease …

Purpose To determine the utility of cross-sectional area (CSA) measurements on magnetic
resonance imaging (MRI), at the level of the thigh muscles, to estimate muscle mass in …